News
The promise of regenerative medicine through stem-cell therapy is intoxicating ... In both approaches, embryo transfer takes place 24–48 hours after removal of a blastomere or polar body ...
22d
ScienceAlert on MSNExperimental Drug Tested in Mice Repairs The Eye to Restore VisionOur eyes could potentially be coaxed into a special repair mode above and beyond our natural self-healing abilities, according to a new study, thanks to the delivery of antibodies that trigger nerve ...
Kincell Bio is focused on supporting innovative companies developing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programs, as well as developing expertise in ...
by Treatment Type, 2020-2034 Table 03: Global Aplastic Anemia Market Size (US$ Bn) Forecast, by End-user, 2020-2034 Table 04: Global Aplastic Anemia Market Size (US$ Bn) Forecast, by Mode of ...
People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may ...
Backed by science and real results, Swiss Medica is leading the way in regenerative stem cell therapies with personalized treatments that go beyond symptom management to restore function and quality ...
Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...
YOKNEAM, Israel, May 19, 2025 /PRNewswire/ -- Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSC), reported today data of an ...
This approach increases neurite outgrowth by 90%, addressing key limitations in stem cell therapy for neurodegenerative diseases and offering improved precision and efficacy for neural regeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results